Fractional CTO for Pharmaceuticals & Life Sciences

Part of the mandate is to make ourselves unnecessary. We plan for your full-time hire from the start rather than building dependency.

In pharmaceuticals & life sciences, GxP validation means every system change needs documented evidence before it reaches production. That single fact reshapes how fractional cto has to be built here, the guardrails, the approval points and the evidence trail are design inputs rather than things bolted on before go-live.

The workload we are most often asked to take on first is adverse event intake and coding, usually integrated against LIMS. Every engagement opens with a measurement: the cycle time, the cost per transaction, or the error rate we are being asked to move.

Built by engineers who ship production systems, not by a practice that subcontracts the build. We hand over with runbooks, tests and a team that knows how it works, not a dependency.